CALCIMEDICA, INC.

Insiders CalciMedica, Inc.

Equities

CALC

US38942Q2021

End-of-day quote Nasdaq Other stock markets 23:00:00 14/05/2024 BST			5-day change	1st Jan Change
5.48 ^USD	-1.26%		-3.01%	+91.61%

05-13	CalciMedica, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-24	Calcimedica Inc. Announces Last Patient Enrolled in Phase 2B Carpo Trial of Auxora? in Acute Pancreatitis	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Calcimedica Insider Bought Shares Worth $2,515,080, According to a Recent SEC Filing	01-26	MT
CalciMedicaAnnounces Executive Changes	22/03/23	CI
Graybug Vision, Inc. will Change its Name to CalciMedica, Inc	21/03/23	CI
Graybug Vision, Inc. Announces Parisa Zamiri Cease to Serve as Chief Medical Officer	03/03/23	CI
Graybug Vision, Inc. Announces Board Changes	09/02/23	CI
Graybug Vision, Inc. Appoints Dirk Sauer to Board of Directors	13/04/22	CI
Graybug Vision Appoints Bettina Maunz as Chief People Officer	01/02/21	CI
Graybug Vision, Inc. Appoints Three New Members to Board of Directors	25/09/20	CI
Graybug Vision, Inc. Announces Executive Changes	03/08/20	CI
Graybug Vision, Inc. Appoints Parisa Zamiri as Chief Medical Officer	18/05/20	CI
Graybug Vision, Inc. Appoints Frederic Guerard as Chief Executive Officer	05/02/19	CI
Graybug Vision, Inc Announces Executive Appointments	11/12/17	CI
Graybug Vision, Inc. Appoints Valerie Smith as VP, Global Clinical Development Operations	08/05/17	CI
Graybug Vision, Inc. Names Thomas S. Templeman as Chief Operating Officer	03/01/17	CI
Graybug Vision, Inc. Announces Executive Appointments	21/06/16	CI
GrayBug, Inc. Announces Management Appointments	21/05/15	CI
GrayBug, LLC Appoints Michael O'Rourke as President, CEO and Board Member	28/10/13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer